Milanova Tsveta (CIK 1957180) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-06). Recent activity: Sell AGIO (3,262 shares), Buy AGIO (8,500 shares), Buy AGIO (4,000 shares), Buy AGIO (5,666 shares), Sell AGIO (1,681 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-06 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Sell | 3,262 | $113,224 |
| 2026-04-06 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Buy | 8,500 | $0 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Buy | 4,000 | $0 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Buy | 5,666 | $0 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Sell | 1,681 | $48,682 |
| 2026-03-03 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Sell | 1,187 | $34,376 |
| 2026-01-07 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Buy | 8,475 | $0 |
| 2026-01-07 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Sell | 2,872 | $77,601 |
| 2026-01-02 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Buy | 6,000 | $0 |
| 2026-01-02 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Sell | 2,932 | $79,428 |
| 2025-06-26 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Buy | 6,000 | $0 |
| 2025-06-26 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Sell | 2,770 | $92,906 |
| 2025-03-04 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Buy | 5,667 | $0 |
| 2025-03-04 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Chief Commercial Officer | Sell | 1,681 | $59,743 |
Source: SEC Form 4 filings · as of 2026-04-06